Poster Author Of 2 e-Posters
12 - Results from the REPAIR Study: Effects of Macitentan on Right Ventricular (RV) Remodelling in Pulmonary Arterial Hypertension (PAH)
Presentation Number
12
Session Name
SESSION 05 - ORAL: Pulmonary Hypertension: Where We're Going We Don't Need Roads
Date
Wed, Apr 22, 2020
Time
10:30 AM - 12:15 PM
Authors
- A. Vonk Noordegraaf, Amsterdam, Netherlands
- R. Channick, Los Angeles, CA, United States of America
- E. Cottreel, Allschwil, Switzerland
- D. Kiely, Sheffield, United Kingdom
- N. Martin, Allschwil, Switzerland
- O. Moiseeva, St Petersburg, Russian Federation
- A. Peacock, Glasgow, United Kingdom
- A. Tawakol, Boston, MA, United States of America
- A. Torbicki, Otwock, Poland
- S. Rosenkranz, Cologne, Germany
- N. Galiè, Bologna, Italy
1310 - Treatment of Drug- and Toxin-Induced Pulmonary Arterial Hypertension (PAH): Real-World Experience with Macitentan
Presentation Number
1310
Session Name
POSTER SESSION 3 - POSTER SESSION: Pulmonary Hypertension and CTEPH
Date
Fri, Apr 24, 2020
Time
06:00 PM - 07:15 PM
Authors
- A. Ravichandran, Indianapolis, IN, United States of America
- R. Channick, Los Angeles, CA, United States of America
- K. Chin, Dallas, TX, United States of America
- V. McLaughlin, Ann Arbor, MI, United States of America
- R. Zamanian, Stanford, CA, United States of America
- M. Flynn, South San Francisco, CA, United States of America
- S. Leroy, Allschwil, Switzerland
- R. Ong, Allschwil, Switzerland
- G. Wetherill, Allschwil, Switzerland
- N. Kim, La Jolla, CA, United States of America